6,8-Di-chloro-3-(pyridin-2-yl)-2-[1-(pyridin-2-yl)eth-yl]-1,2-di-hydro-quinoxaline

Frederick P Malan; Ahmed M Mansour; Amanda-Lee E Manicum

doi:10.1107/S241431462300665X

6,8-Di-chloro-3-(pyridin-2-yl)-2-[1-(pyridin-2-yl)eth-yl]-1,2-di-hydro-quinoxaline

IUCrdata. 2023 Aug 4;8(Pt 8):x230665. doi: 10.1107/S241431462300665X. eCollection 2023 Aug.

Authors

Frederick P Malan¹, Ahmed M Mansour², Amanda-Lee E Manicum³

Affiliations

¹ Department of Chemistry, University of Pretoria, 0002, Pretoria, South Africa.
² Department of Chemistry, Faculty of Science, Cairo University, Gamma Street, Giza, Cairo 12613, Egypt.
³ Department of Chemistry, Tshwane, University of Technology, 0001, Pretoria, South Africa.

Abstract

The crystal structure of the racemic title compound, C₂₀H₁₆C_l2N₄ is described, where the formation of a di-substituted 6,8-di-chloro quinoxaline, containing two stereogenic centres, is confirmed.

Keywords: chiral compound; crystal structure; quinoxaline derivative.

Grants and funding

Funding for this research was provided by: National Research Foundation (grant No. 138280 to FPM; grant No. 129468 to ALEM).